Ambrisentan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 518 publications

Next-generation therapeutics and renaissance of legacy drugs targeting the endothelin system.

Next-generation therapeutics and renaissance of legacy drugs targeting the endothelin system.

Journal: Canadian journal of physiology and pharmacology

Published: June 30, 2026

A novel TRPC6 variant (c.131C>T, p.(Pro44Leu)) associated with focal segmental glomerulosclerosis: a case report.

A novel TRPC6 variant (c.131C>T, p.(Pro44Leu)) associated with focal segmental glomerulosclerosis: a case report.

Journal: Frontiers in genetics

Published: June 18, 2026

A Rare Case of Pulmonary Arterial Hypertension in a Patient With Breast Cancer Treated With Trastuzumab Emtansine.

A Rare Case of Pulmonary Arterial Hypertension in a Patient With Breast Cancer Treated With Trastuzumab Emtansine.

Journal: Cureus

Published: May 17, 2026

Modulation of ET1/NF-κB/IL-6/STAT-4/AP-1 pathway by ambrisentan alleviates isoprenaline-induced myocardial injury.

Modulation of ET1/NF-κB/IL-6/STAT-4/AP-1 pathway by ambrisentan alleviates isoprenaline-induced myocardial injury.

Journal: Immunopharmacology and immunotoxicology

Published: May 15, 2026

Sepsis reporting signals associated with endothelin receptor antagonists and IFITM3-Centered interferon-responsive monocyte features: a pharmacovigilance and transcriptomic study.

Sepsis reporting signals associated with endothelin receptor antagonists and IFITM3-Centered interferon-responsive monocyte features: a pharmacovigilance and transcriptomic study.

Journal: Frontiers in pharmacology

Published: April 28, 2026

Exploring the therapeutic landscape of pulmonary hypertension associated with interstitial lung disease, with a focus on idiopathic pulmonary fibrosis: a narrative review.

Exploring the therapeutic landscape of pulmonary hypertension associated with interstitial lung disease, with a focus on idiopathic pulmonary fibrosis: a narrative review.

Journal: Frontiers in pharmacology

Published: April 26, 2026

Targeting PI3K/Akt/mTOR Pathway, Ki-67 and Endothelin Receptors by Ambrisentan in Juvenile Rat Intestinal Ischemia.

Targeting PI3K/Akt/mTOR Pathway, Ki-67 and Endothelin Receptors by Ambrisentan in Juvenile Rat Intestinal Ischemia.

Journal: International journal of molecular sciences

Published: April 23, 2026

Ambrisentan Exhibits Hepatoprotective Effects Against NASH-Associated Hepatic Injury in Dexamethasone-Treated Rats Through Regulation of Inflammation, Ferroptosis and Autophagy.

Ambrisentan Exhibits Hepatoprotective Effects Against NASH-Associated Hepatic Injury in Dexamethasone-Treated Rats Through Regulation of Inflammation, Ferroptosis and Autophagy.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: April 16, 2026

A Rare Case of Multi-System Involvement and Hereditary Pulmonary Hypertension Caused by De Novo Heterozygous CAV1 Mutation in a Pediatric Patient.

A Rare Case of Multi-System Involvement and Hereditary Pulmonary Hypertension Caused by De Novo Heterozygous CAV1 Mutation in a Pediatric Patient.

Journal: Children (Basel, Switzerland)

Published: April 13, 2026

Comparative clinical evaluation of endothelin receptor antagonists in pulmonary arterial hypertension using a multi-criteria decision analysis framework.

Comparative clinical evaluation of endothelin receptor antagonists in pulmonary arterial hypertension using a multi-criteria decision analysis framework.

Journal: International journal of clinical pharmacy

Published: April 03, 2026

Evidence Gap and Challenges in the Management of Mild Pulmonary Hypertension.

Evidence Gap and Challenges in the Management of Mild Pulmonary Hypertension.

Journal: JACC. Asia

Published: March 19, 2026

Development of a population pharmacokinetic model using combined paediatric and adult data for four pulmonary arterial hypertension drugs.

Development of a population pharmacokinetic model using combined paediatric and adult data for four pulmonary arterial hypertension drugs.

Journal: British journal of clinical pharmacology

Published: January 31, 2026

Showing 1-12 of 518

Last Updated: 09/26/2026